DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Kim ES, Hirsh V, Mok T et al.
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
Lancet 2008;
372: 1809-1818
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.